 Oncternal Therapeutics, Inc. NASDAQ:ONCT Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Rich Vincent - Chief Financial Officer Dr. James Breitmeyer - President and CEO Dr. Salim Yazji - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer Carl Byrnes - Northland Capital Markets Robert Burns - H.C. Wainwright Kenny Storch - BTIG Operator Ladies and chairman, greetings and welcome to the Oncternal Therapeutics, Inc. Q3 2022 Financial Results Call. 